Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aquestive Therapeutics Inc
(NQ:
AQST
)
5.030
-0.260 (-4.91%)
Streaming Delayed Price
Updated: 12:29 PM EST, Mar 2, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Aquestive Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Today 8:01 EST
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
AQST
XENE
FGEN
From
Benzinga
Pomerantz Law Firm Announces the Filing of a Class Action against Aquestive Therapeutics, Inc. and Certain Officers - AQST
March 01, 2021
Pomerantz LLP announces that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ: AQST) and certain of its officers. The class action,...
From
PR Newswire
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
February 28, 2021
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ...
Tags
PCRX
News
ZEAL
From
Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
February 27, 2021
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ...
Tags
BOLT
Penny Stocks
TERN
From
Benzinga
Analysts Expect 11% Gains Ahead For IWO
February 26, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aquestive Sees Libervant Application Resubmission By End Of Q2
February 25, 2021
TheFDA has provided further guidancetoAquestive Therapeutics Inc(NASDAQ:AQST) regarding the information ...
Tags
Benzinga
Market News
FDA
From
Benzinga
Aquestive Therapeutics Reaffirms Near-Term NDA Resubmission for Libervant™ (diazepam) Buccal Film Following FDA Feedback
February 25, 2021
From
GlobeNewswire News Releases
Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET
February 17, 2021
From
GlobeNewswire News Releases
Notable Two Hundred Day Moving Average Cross - AQST
February 16, 2021
In trading on Tuesday, shares of Aquestive Therapeutics Inc (AQST) crossed below their 200 day moving average of $5.95, changing hands as low as $5.91 per share. Aquestive Therapeutics Inc shares are...
Tags
Stocks
From
Market News Video
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors
February 09, 2021
From
GlobeNewswire News Releases
Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy
January 28, 2021
From
GlobeNewswire News Releases
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce U.S. Licensing and Supply Deal for Riluzole Oral Film for ALS Treatment
January 21, 2021
Mitsubishi Tanabe Pharma America, Inc. (MTPA) and Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced a licensing and supply deal for the U.S. rights to commercialize EXSERVAN™ (riluzole), an...
From
PR Newswire
Aquestive Therapeutics Provides Business Update
January 07, 2021
From
GlobeNewswire News Releases
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
January 04, 2021
From
GlobeNewswire News Releases
Interesting AQST Put And Call Options For August 2021
December 18, 2020
Investors in Aquestive Therapeutics Inc (AQST) saw new options become available this week, for the August 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to...
Tags
Stocks
From
Market News Video
Aquestive Therapeutics Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer
December 16, 2020
From
GlobeNewswire News Releases
How The Pieces Add Up: DWAS Headed For $80
December 15, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
November 25, 2020
From
GlobeNewswire News Releases
Aquestive Therapeutics Receives First Milestone Payment from KYNMOBI™ Monetization
November 23, 2020
Receives first milestone payment of $10 million, bringing total fourth quarter proceeds to $50 million
From
GlobeNewswire News Releases
68 Biggest Movers From Yesterday
November 20, 2020
Gainers Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) gained 157.9% to close at $49.00 after the company priced its IPO at $19 per ...
Tags
SCYX
Markets
AYRO
From
Benzinga
Why Aquestive Therapeutics Stock Is Trading Higher Today
November 19, 2020
Aquestive Therapeutics (NASDAQ: AQST) shares are trading higher on Thursday after the company announced the completion of a Type A ...
Tags
Benzinga
AQST
why it's moving
From
Benzinga
12 Healthcare Stocks Moving In Thursday's Intraday Session
November 19, 2020
Gainers Titan Pharmaceuticals (NASDAQ:TTNP) stock increased by 37.5% to $0.17 during Thursday's regular session. As ...
Tags
BLI
KTRA
Top Gainers
From
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
November 19, 2020
Gainers Naked Brand Group Limited (NASDAQ: NAKD) shares jumped 77.7% to $0.2302 after jumping around 47% on Wednesday. Phoenix ...
Tags
AKBA
KTRA
ZTO
From
Benzinga
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
November 19, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
KZIA
News
PCRX
From
Benzinga
34 Stocks Moving in Thursday's Pre-Market Session
November 19, 2020
Gainers Hudson Capital Inc. (NASDAQ: HUSN) shares rose 44.2% to $3.23 in pre-market trading. Hudson Capital, on Monday, said it ...
Tags
Movers
SONO
Small Cap
From
Benzinga
8 Stocks Moving In Wednesday's After-Hours Session
November 18, 2020
Gainers Corcept Therapeutics (NASDAQ: CORT) shares are trading higher after as traders circulate a November 18 USPTO court ...
Tags
SONO
AQST
News
From
Benzinga
12 Healthcare Stocks Moving In Wednesday's After-Market Session
November 18, 2020
Gainers Corcept Therapeutics (NASDAQ:CORT) shares rose 22.99% to $22.95 during Wednesday's after-market session. At the close, ...
Tags
ORTX
Movers
RGLS
From
Benzinga
Aquestive Therapeutics Completes FDA Type A Meeting on Libervant
November 18, 2020
From
GlobeNewswire News Releases
54 Stocks Moving In Friday's Mid-Day Session
November 13, 2020
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares climbed 94% to $16.06 after the company late Thursday announced Sumitovant ...
Tags
Intraday Update
Trading Ideas
Penny Stocks
From
Benzinga
How The Parts Add Up: DWAS Headed For $75
November 10, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.